HIGHLIGHTS
- who: Valentina D. A. Corino and colleagues from the Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, Milan, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy have published the paper: A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study, in the Journal: (JOURNAL)
- what: The aim of the trial was to assess the incidence of high-grade (grade 3 or higher), treatment-related, selected adverse events (AE); secondary objectives were to characterize the outcome of all AE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.